Analyst Ratings For Vanda Pharmaceuticals (NASDAQ:VNDA) (NASDAQ:VNDA)
Today, Oppenheimer reiterated its Buy rating on Vanda Pharmaceuticals (NASDAQ:VNDA) (NASDAQ:VNDA).
Some recent analyst ratings include
- 3/22/2018-Oppenheimer Reiterated Rating of Buy.
- 2/28/2018-Seaport Global Securities Reiterated Rating of Buy.
- 2/13/2018-Jefferies Group Reiterated Rating of Buy.
- 4/12/2017-CIBC Reiterated Rating of Outperform .
- 11/9/2016-Aegis initiated coverage with a Buy rating.
Recent Insider Trading Activity For Vanda Pharmaceuticals (NASDAQ:VNDA) (NASDAQ:VNDA)
Vanda Pharmaceuticals (NASDAQ:VNDA) (NASDAQ:VNDA) has insider ownership of 7.60% and institutional ownership of 89.96%.
- On 3/1/2018 Gunther Birznieks, SVP, sold 8,525 with an average share price of $18.72 per share and the total transaction amounting to $159,588.00.
- On 3/1/2018 James Patrick Kelly, CFO, sold 8,532 with an average share price of $18.72 per share and the total transaction amounting to $159,719.04.
- On 3/1/2018 Mihael Hristos Polymeropoulos, Insider, sold 60,966 with an average share price of $18.72 per share and the total transaction amounting to $1,141,283.52.
- On 1/2/2018 Gunther Birznieks, SVP, sold 8,568 with an average share price of $15.26 per share and the total transaction amounting to $130,747.68.
- On 1/2/2018 James Patrick Kelly, CFO, sold 9,155 with an average share price of $15.35 per share and the total transaction amounting to $140,529.25.
- On 1/2/2018 Mihael Hristos Polymeropoulos, Insider, sold 191,760 with an average share price of $15.30 per share and the total transaction amounting to $2,933,928.00.
- On 1/3/2017 Richard L Gulino, SVP, sold 10,900 with an average share price of $15.51 per share and the total transaction amounting to $169,059.00.
Recent Trading Activity for Vanda Pharmaceuticals (NASDAQ:VNDA) (NASDAQ:VNDA)
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) closed the previous trading session at 17.12 up +0.17 1.03% with 532558 shares trading hands.